Results 101 to 110 of about 825,693 (294)

Bepridil for Persistent Atrial Fibrillation

Journal of Arrhythmia, 2011
Bepridil was originally developed as an anti-angina drug which suppresses mainly L and T type calcium channels, several potassium channels, and fast kinetic sodium channel of the myocardial cells. Bepridil has been used for restoring sinus rhythm and maintenance of sinus rhythm in patients with long-lasting atrial fibrillation in Japan.
openaire   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Duration of Persistent Atrial Fibrillation Is Associated with Alterations in Human Gut Microbiota and Metabolic Phenotypes

mSystems, 2019
Atrial fibrillation (AF) has been shown to be associated with disordered gut microbiota (GM). The underlying factors governing persistent AF (psAF) are not well understood, and the association between AF duration and GM profiles remains to be ...
Kun Zuo, Jing Li, Pan Wang, Ye Liu, Zheng Liu, Xiandong Yin, Xiaoqing Liu, Xinchun Yang   +7 more
doaj   +1 more source

Predictors of persistent or permanent atrial fibrillation.

, 2016
Predictors of persistent or permanent atrial fibrillation.
Ju Hyeon Kim (1803442), You Mi Hwang (2901215), Kee-Joon Choi (2901209), You-Ho Kim (2901212), Min Soo Cho (2901224), Jun Kim (238502), Ji Hyun Lee (16823), Minsu Kim (716600), Uk Jo (2901218), Gi-Byoung Nam (2901221)   +9 more
core   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting

BMC Cardiovascular Disorders, 2017
Background Studies have demonstrated that catheter ablation of atrial fibrillation is associated with better rhythm control than drug therapy. The present study aimed to assess the clinical outcomes and health-related quality of life of ablation therapy ...
Xin Du, Lizhu Guo, Xiaonan He, Yu Jia, Jiahui Wu, Deyong Long, Ronghui Yu, Caihua Sang, Xiaohui Liu, Hongjun Yin, Jianwei Xuan, Jianzeng Dong, Changsheng Ma   +12 more
doaj   +1 more source

Ranolazine in Persistent Atrial Fibrillation

JACC: Case Reports
Direct-current cardioversion (DCCV) is used as a rhythm-control strategy in persistent symptomatic atrial fibrillation (AF) and is often supported by antiarrhythmic drugs (AADs), usually class III AADs, to improve outcomes. Although primarily used as an antianginal agent, ranolazine has also shown evidence of antiarrhythmic properties in AF.We detail ...
Raman, Sagarika, Rutherford, Philip, Presslie, Calum, Thomas, Honey, Bandali, Alykhan, Das, Moloy   +5 more
openaire   +2 more sources

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

, 2013
BackgroundThe relationship between non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) in type 2 diabetes is currently unknown. We examined the relationship between NAFLD and risk of incident AF in people with type 2 diabetes.Methods ...
Zoppini Giacomo, S. Rodella, Filippo Valbusa, Mantovani William, Mantovani, W., BARBIERI, Enrico, Bertolini Lorenzo, ZOPPINI, Giacomo, L. Zenari, Byrne Christopher D., Zoppini, G., Giacomo Zoppini, Stefano Bonapace, Byrne, Christopher D., Stefano Rodella, Bertolini, L., CD Byrne, Bonapace Stefano, Giovanni Targher, L. Bertolini, Targher, G., Bonapace, S., Valbusa, F., Targher Giovanni, Christopher D Byrne, TARGHER, Giovanni, F. Valbusa, Barbieri, E., MANTOVANI, William, Barbieri Enrico, Rodella, S., Enrico Barbieri, Valbusa Filippo, Luciano Zenari, Zenari, L., William Mantovani, Rodella Stefano, Lorenzo Bertolini, Zenari Luciano, S. Bonapace   +39 more
core   +1 more source